Delivery Order SPE2DB22D2211-SPE2DB25FRZLD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a contract ceiling value of $2,854.12. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, representing a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The award carries no set-aside designation, indicating it was competitively awarded to the...
- The Defense Logistics Agency awarded a delivery order valued at $16,681.52 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine 800 mg delayed-release tablets (180-count quantity) under a firm fixed-price contract valued at $1,520.96. The award, issued on June 27, 2025, is a non-set-aside competitive delivery order with an ultimate completion date of June 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $1,199.18. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under a larger contract vehicle, leveraging...
- The Defense Logistics Agency awarded a $6,571.87 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count supply) with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count) under a firm fixed-price contract. The order, valued at $40,028.47, is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,914.97. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is set to be completed by July 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,764.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the open competition...
- The Defense Logistics Agency awarded a $17,412.86 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $11,163.06 to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication. The contract employs firm fixed-price pricing with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRZLDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a ceiling value of $8,263.21. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's prime IDC with DLA provides a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order falls within that strategic framework, supporting the Defense Health Agency and other government healthcare systems requiring pharmaceutical supplies for active-duty personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 6/20/25 |